Dell Technologies Capital contributed to a round that more than doubled the container security software provider's overall funding to $63m.

Maxim Integrated and Tasly Pharmaceutical contributed to Profusa's series C round, which will fund commercialisation of its biosensor technology.

Sphera Global Health Care and Medison were among the participants in a round that took Orchard Therapeutics' overall funding past $290m.

Online pharmacist Capsule has taken new funding, just over a year after its Virgin-backed series A round.

Giant Network Group has returned for the co-working space provider's latest round, having backed its series B in March.

Illumina, GV and Orient Life supported a $72m series C round for MIT spinout SQZ Biotechnology, with the money set to fund therapies for solid tumours and autoimmunity.

NGP Capital led a series C round for the on-demand delivery services provider that included Qualcomm Ventures, taking its total funding to about $41m.

Illumina, GV and Orient Life supported a $72m series C round for SQZ Biotechnology, with the money set to fund therapies for solid tumours and autoimmunity.